fda_approval · anda · info

NORWICH — ANDA approval: BALOXAVIR MARBOXIL (unspecified)

Event date
2026-06-17 00:00:00Z
Observed
2026-07-09 22:53:30Z
Source ID
ANDA217449-1
Payload hash
9aa1ebccd0c02a9f91e19591

Summary

NORWICH received ANDA approval for BALOXAVIR MARBOXIL (unspecified) on 2026-06-17. Dosage form: TABLET. Application #: ANDA217449.

Entities

Informational only. Not legal, financial, or medical advice.